TINJOY HEALTH CUBE AND APP UPDATE [IMAGE INTENSIVE], page-8

I understand the Nasdaq listing is a CR in and of itself.

My question over the past few days has been whether can we get the listing across the line in time or if our monthly cash burn will force one final ASX CR before we dual list.

Ideally not, but we are delayed on a Nasdaq basis by several months now (possibly 5-6 months?) and without receipt from customers, there's only one way the the bank account is going and that is down.

I'm not sure whether we financed last years R&D refund, but if we did, that's likely due for payment shortly on the assumption that the R&D Schedule and subsequent ITR were lodged early in FY 2021.

Hopefully Vlado and co are well on their way to having the FY 2021 R&D Schedule completed so that we can finance that now as that could flush the kitty with a couple hundred thousand. Our FY 20 refund (received Oct 2020) was $784,412.